DBV Technologies Overview
- Founded
- 2002

- Status
- Public
- Employees
- 311

- Stock Symbol
- DBV

- Share Price
- $13.35
- (As of Wednesday Closing)
DBV Technologies General Information
Description
DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. DBV's method of delivering biologically active compounds to the immune system is through self-administered and noninvasive products. The company also explores potential applications of its platform in vaccines and other immune diseases.
Contact Information
- 177-181 Avenue Pierre Brossolette
- 92120 Montrouge
- France
DBV Technologies Timeline
DBV Technologies Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$13.35 | $12.51 | $2.75 - $25.47 | $732M | 54.8M | 1.65M | -$3.69 |
DBV Technologies Financials Summary
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 320,913 | 941,131 | 135,824 | 1,027,095 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (175,029) | (163,439) | (192,787) | (160,208) |
Net Income | (177,299) | (171,932) | (195,981) | (166,563) |
Total Assets | 337,012 | 270,495 | 196,464 | 213,315 |
Total Debt | 25,360 | 27,634 | 4,385 | 5,507 |
DBV Technologies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore DBV Technologies‘s full profile, request access.
Request a free trialDBV Technologies Comparisons
Industry
000000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialDBV Technologies Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Viriom | Venture Capital-Backed | San Diego, CA | 0 | 00.000 | 0000000000 0 | 00.000 |
000000 | Formerly VC-backed | Lyon, France | 000 | 000.00 | 00000000 | 000.00 |
0000000 0000000000 | Formerly VC-backed | Brisbane, CA | 000 | 00000 | 000000&0 | 00000 |
0000000 | Formerly VC-backed | Summit, NJ | 0000 | 000.00 | 000000&0 | 000.00 |
000000000 | Formerly VC-backed | South San Francisco, CA | 00000 | 000.00 | 00000000000 |
DBV Technologies Executive Team (18)
DBV Technologies Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Soland | Self | Board Member | 000 0000 |
Maïlys Ferrère | Self | Board Member | 000 0000 |
Michael Goller | DBV Technologies | Board Member | 000 0000 |
Michel De Rosen | DBV Technologies | Chairman & Board Member | 000 0000 |
Torbjörn Bjerke MD | Self | Board Member | 000 0000 |
DBV Technologies Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDBV Technologies Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore DBV Technologies‘s full profile, request access.
Request a free trial